Search Results - "ELLINGROD, Vicki L"

Refine Results
  1. 1

    Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort by Flowers, Stephanie A., Evans, Simon J., Ward, Kristen M., McInnis, Melvin G., Ellingrod, Vicki L.

    Published in Pharmacotherapy (01-03-2017)
    “…Objectives The atypical antipsychotic (AAP) class is often associated with metabolic disease, but the mechanistic underpinnings of this risk are not…”
    Get full text
    Journal Article
  2. 2

    Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer by O'Malley, Meaghan, King, Amanda N, Conte, Marisa, Ellingrod, Vicki L, Ramnath, Nithya

    Published in Journal of thoracic oncology (01-07-2014)
    “…Cigarette smoke associated polycyclic aromatic hydrocarbons can induce key drug-metabolizing enzymes of cytochrome P450 and isoforms of the glucuronyl…”
    Get more information
    Journal Article
  3. 3

    Antipsychotic-Induced Hyperprolactinemia by Bostwick, Jolene R., Guthrie, Sally K., Ellingrod, Vicki L.

    Published in Pharmacotherapy (01-01-2009)
    “…Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can interfere with the…”
    Get full text
    Journal Article
  4. 4

    Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance by Burghardt, Kyle J, Goodrich, Jacyln M, Dolinoy, Dana C, Ellingrod, Vicki L

    Published in Bipolar disorders (01-08-2016)
    “…Objectives Atypical antipsychotics (AAPs) carry a significant risk of cardiometabolic side effects, including insulin resistance. It is thought that the…”
    Get full text
    Journal Article
  5. 5

    122 DIAMOND 2.0: Updating a Pioneering Digital Platform for Study Team Workforce Development by Eakin, Brenda, Samuels, Elias, Ellingrod, Vicki L.

    “…OBJECTIVES/GOALS: There is a critical need to provide quality training for study teams. Materials need to be flexible and available at the learner’s preferred…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics by Ward, Kristen M, Burghardt, Kyle, Kraal, A Zarina, Jaeger, Andrew, Yeomans, Larisa, McHugh, Cora, Karnovsky, Alla, Stringer, Kathleen A, Ellingrod, Vicki L

    Published in Frontiers in psychiatry (25-05-2021)
    “…Patients with schizophrenia are at high risk of pre-mature mortality due to cardiovascular disease (CVD). Our group has completed studies in pharmacogenomics…”
    Get full text
    Journal Article
  8. 8

    DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder by Burghardt, Kyle J, Goodrich, Jacyln M, Dolinoy, Dana C, Ellingrod, Vicki L

    Published in Epigenomics (01-06-2015)
    “…This study aimed to assess the effect of second-generation antipsychotic (SGA) use and insulin resistance on a global measure of DNA methylation in patients…”
    Get full text
    Journal Article
  9. 9

    The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia by Ellingrod, Vicki L., Lines, Brittany N., Goodrich, Jacyln M., Burghardt, Kyle J.

    Published in International journal of genomics (01-01-2018)
    “…Introduction. The mechanism by which metabolic syndrome occurs in schizophrenia is not completely known; however, previous work suggests that changes in DNA…”
    Get full text
    Journal Article
  10. 10

    Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects by Evans, Simon J, Prossin, Alan R, Harrington, Gloria J, Kamali, Masoud, Ellingrod, Vicki L, Burant, Charles F, McInnis, Melvin G

    Published in PloS one (13-01-2012)
    “…Polyunsaturated fatty acids (PUFA) have shown efficacy in the treatment of bipolar disorder, however their specific role in treating the illness is unclear…”
    Get full text
    Journal Article
  11. 11

    Reimagining a summer research program during COVID: Strategies for enhancing research workforce diversity by Eakin, Brenda L, Ianni, Phillip A, Byks-Jazayeri, Christy, Ellingrod, Vicki L, Woolford, Susan J

    “…Well-designed, accessible short-term research training programs are needed to recruit and retain underrepresented persons into clinical and translational…”
    Get full text
    Journal Article
  12. 12

    Implementing and measuring the impact of a clinical and translational research mentor recognition program by Byks-Jazayeri, Christine, Samuels, Elias, Anderson, Elizabeth W, Ellingrod, Vicki L

    “…Research shows incentives can motivate faculty to increase their engagement in mentoring, despite a myriad of institutional barriers. One such incentive may be…”
    Get full text
    Journal Article
  13. 13

    Indices of Clinical Research Coordinators' Competence by Hornung, Carlton A, Ianni, Phillip A, Jones, Carolynn T, Samuels, Elias M, Ellingrod, Vicki L

    “…There is a clear need to educate and train the clinical research workforce to conduct scientifically sound clinical research. Meeting this need requires the…”
    Get full text
    Journal Article
  14. 14

    Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment by Bishop, Jeffrey R., Ellingrod, Vicki L., Moline, Jessica, Miller, Del

    Published in Schizophrenia research (15-09-2005)
    “…The excitatory neurotransmitter glutamate has become an important area of focus for schizophrenia researchers. Polymorphisms in the type-three metabotropic…”
    Get full text
    Journal Article
  15. 15

    Pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions by Thomas, Kelan L. H., Ellingrod, Vicki L.

    Published in Pharmacotherapy (01-07-2009)
    “…The selective serotonin reuptake inhibitors (SSRIs) have become one of the most widely prescribed classes of drugs. They are relatively safe for the…”
    Get full text
    Journal Article
  16. 16

    Depressive Symptoms Longitudinally Mediate the Effect of Hyperglycemia on Memory Decline in Type 2 Diabetes by Kraal, A Zarina, Ellingrod, Vicki L, Zahodne, Laura B

    Published in Diabetes care (01-09-2023)
    “…We sought to examine the mediating role of changes in depressive symptoms in the association between chronic hyperglycemia and longitudinal cognition in a…”
    Get full text
    Journal Article
  17. 17

    The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis by Taylor, Stephan F, Grove, Tyler B, Ellingrod, Vicki L, Tso, Ivy F

    Published in Schizophrenia bulletin (24-10-2019)
    “…Persons with schizophrenia exhibit sensitivity to stress and negative affect (NA), both strongly correlated with poor functional outcome. This theoretical…”
    Get full text
    Journal Article
  18. 18

    Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia by Bishop, Jeffrey R., Miller, Del D., Ellingrod, Vicki L., Holman, Timothy

    Published in Human psychopharmacology (01-01-2011)
    “…Objective Positive associations between polymorphisms in the type‐three metabotropic glutamate receptor gene (GRM3) and the pathogenesis of schizophrenia as…”
    Get full text
    Journal Article
  19. 19

    A systematic review of clozapine‐associated inflammation and related monitoring by Leung, Jonathan G., Zhang, Lusi, Markota, Matej, Ellingrod, Vicki L., Gerberi, Danielle J., Bishop, Jeffrey R.

    Published in Pharmacotherapy (01-12-2023)
    “…Clozapine is an effective antipsychotic medication used for treatment‐resistant schizophrenia. However, it is underutilized due to rigorous hematologic…”
    Get full text
    Journal Article
  20. 20